33 related articles for article (PubMed ID: 27224875)
1. Discovery of potent and novel dual NAMPT/BRD4 inhibitors for efficient treatment of hepatocellular carcinoma.
Yin C; Jia S; Yang X; Wu L
Eur J Med Chem; 2024 May; 271():116444. PubMed ID: 38691889
[TBL] [Abstract][Full Text] [Related]
2. Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma.
Liu Z; Lin M; Liu C; Chen X; Chen Q; Li X; Wu X; Wang Y; Wang L; Yang F; Luo C; Jin J; Ye F
J Med Chem; 2024 Apr; 67(8):6313-6326. PubMed ID: 38574345
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Dual Inhibitors Targeting Mutant IDH1 and NAMPT for the Treatment of Glioma with IDH1Mutation.
Wen F; Gui G; Wang X; Qin A; Ma T; Chen H; Li C; Zha X
J Med Chem; 2024 Apr; ():. PubMed ID: 38651495
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-tumor activity evaluation of 1H-pyrrolo[2,3-b]pyridine-2-carboxamide derivatives with phenyl sulfonamide groups as potent RSK2 inhibitors.
Zhang X; Zheng G; Gao S; Zhou F; Pan T; Shi Q; Li J; Zhang X; Huang Z; Quan X
Chem Biol Drug Des; 2024 Jan; 103(1):e14376. PubMed ID: 37852922
[TBL] [Abstract][Full Text] [Related]
5. New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology.
Roulston A; Shore GC
Mol Cell Oncol; 2016 Jan; 3(1):e1052180. PubMed ID: 27308565
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer.
Navas LE; Carnero A
Cells; 2022 Aug; 11(17):. PubMed ID: 36078035
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy.
Galli U; Colombo G; Travelli C; Tron GC; Genazzani AA; Grolla AA
Front Pharmacol; 2020; 11():656. PubMed ID: 32477131
[TBL] [Abstract][Full Text] [Related]
8. The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives.
Christodoulatos GS; Spyrou N; Kadillari J; Psallida S; Dalamaga M
Curr Obes Rep; 2019 Dec; 8(4):413-433. PubMed ID: 31637624
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer.
Sampath D; Zabka TS; Misner DL; O'Brien T; Dragovich PS
Pharmacol Ther; 2015 Jul; 151():16-31. PubMed ID: 25709099
[TBL] [Abstract][Full Text] [Related]
10. Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.
Velma GR; Krider IS; Alves ETM; Courey JM; Laham MS; Thatcher GRJ
J Med Chem; 2024 Apr; 67(8):5999-6026. PubMed ID: 38580317
[TBL] [Abstract][Full Text] [Related]
11. Structure-Based Design of Potent Nicotinamide Phosphoribosyltransferase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities.
Bai J; Liao C; Liu Y; Qin X; Chen J; Qiu Y; Qin D; Li Z; Tu ZC; Jiang S
J Med Chem; 2016 Jun; 59(12):5766-79. PubMed ID: 27224875
[TBL] [Abstract][Full Text] [Related]
12. Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer.
Zhang W; Zhang K; Yao Y; Liu Y; Ni Y; Liao C; Tu Z; Qiu Y; Wang D; Chen D; Qiang L; Li Z; Jiang S
Eur J Med Chem; 2021 Feb; 211():113022. PubMed ID: 33239261
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors.
Zheng X; Baumeister T; Buckmelter AJ; Caligiuri M; Clodfelter KH; Han B; Ho YC; Kley N; Lin J; Reynolds DJ; Sharma G; Smith CC; Wang Z; Dragovich PS; Oh A; Wang W; Zak M; Wang Y; Yuen PW; Bair KW
Bioorg Med Chem Lett; 2014 Jan; 24(1):337-43. PubMed ID: 24279990
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide phosphoribosyltransferase inhibitors, design, preparation, and structure-activity relationship.
Christensen MK; Erichsen KD; Olesen UH; Tjørnelund J; Fristrup P; Thougaard A; Nielsen SJ; Sehested M; Jensen PB; Loza E; Kalvinsh I; Garten A; Kiess W; Björkling F
J Med Chem; 2013 Nov; 56(22):9071-88. PubMed ID: 24164086
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
